Merck KGaA's (MRK) Management Presents at R&D Update Conference - Transcript

6/17/19

Merck KGaA (NYSE:MRK) R&D Update Conference Call June 14, 2019 8:30 AM ET

Company Participants

Constantin Fest – Head-Investor Relations

Luciano Rossetti – Global Head-Research and Development

Rehan Verjee – President-EMD Serono and Global Head-Innovative Medicine Franchises

Joern-Peter Halle – Head-External Innovation and Head-TIP Immuno Oncology

Conference Call Participants

Wimal Kapadia – Bernstein

Joe Lockey – Morgan Stanley

Sachin Jain – Bank of America

Michael Leuchten – UBS

Richard Vosser – JPMorgan

Luisa Hector – Exane

Emily Field – Barclays

Simon Baker – Redburn

Falko Friedrichs – Deutsche Bank

Constantin Fest

Very warm welcome. Thank you, Cynthia. Warm welcome to this R&D Update Call 2019. My name is Constantin Fest, Head of Investor Relations. And I’m delighted to have with me here today Luciano Rossetti; as well as Rehan Verjee. Luciano our Global Head of Research and Development; Rehan, President of EMD Serono and Global Head of the Innovative Medicine Franchises, and also I’m very happy that supporting for the Q&A, we also have Joern-Peter Halle, Head of External Innovation and Head of TIP Immuno Oncology here with us. And in the next few minutes, we’d like to run you through the key slides of this presentation following that, take all of your questions.

Having said that, happy to hand over to Luciano, so start this call.

READ FULL ARTICLE HERE